HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.34M
Enterprise Value 38.48M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)45.16
Price/Book (mrq)1.12
Enterprise Value/Revenue 337.03
Enterprise Value/EBITDA 6-0.82

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-4,906.11%

Management Effectiveness

Return on Assets (ttm)-44.17%
Return on Equity (ttm)-86.19%

Income Statement

Revenue (ttm)229k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-84.50%
Gross Profit (ttm)-746k
EBITDA -10.28M
Net Income Avi to Common (ttm)-8.37M
Diluted EPS (ttm)-0.2340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.24M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)2.61M
Total Debt/Equity (mrq)28.72
Current Ratio (mrq)2.55
Book Value Per Share (mrq)0.19

Cash Flow Statement

Operating Cash Flow (ttm)-7.88M
Levered Free Cash Flow (ttm)-5.69M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.03
52-Week Change 3-33.91%
S&P500 52-Week Change 38.07%
52 Week High 30.6500
52 Week Low 30.1500
50-Day Moving Average 30.2389
200-Day Moving Average 30.2986

Share Statistics

Avg Vol (3 month) 3215.56k
Avg Vol (10 day) 3197.31k
Shares Outstanding 547.75M
Float 46.14M
% Held by Insiders 12.34%
% Held by Institutions 16.67%
Shares Short (Sep 28, 2018) 4396.27k
Short Ratio (Sep 28, 2018) 42.05
Short % of Float (Sep 28, 2018) 40.86%
Short % of Shares Outstanding (Sep 28, 2018) 40.84%
Shares Short (prior month Aug 31, 2018) 4455.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Aug 29, 2016